Measles Research Today is a free monthly online journal that collates and summarizes the latest research about Measles, including details on german measles, symptoms, vaccine, treatment, rubella.

Volume 4 (2007), Issue 6 (June)

1. Large-scale spatial-transmission models of infectious disease.
   Science, 316(5829): 1298-301. [Abstract] [Full-text]
2. HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses.
   Virology, 364(1): 87-94. [Abstract] [Full-text]
3. Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-survey.
   Vaccine, 25(26): 4940-8. [Abstract] [Full-text]
4. Loss of antibody titers and effectiveness of revaccination in post-chemotherapy pediatric sarcoma patients.
   Pediatr Blood Cancer. [Abstract] [Full-text]
5. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses.
   J Gen Virol, 88: 2028-34. [Abstract] [Full-text]
6. Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18.
   Paediatr Perinat Epidemiol, 21(4): 376-84. [Abstract] [Full-text]
7. Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment.
   Cancer Gene Ther, 14(7): 627-39. [Abstract] [Full-text]
8. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion.
   J Virol, 81(13): 6827-36. [Abstract] [Full-text]
9. Interaction of the C-terminal domains of sendai virus N and P proteins: comparison of polymerase-nucleocapsid interactions within the paramyxovirus family.
   J Virol, 81(13): 6807-16. [Abstract] [Full-text]
10. Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students.
    Med Microbiol Immunol, 196(3): 145-50. [Abstract] [Full-text]
11. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.
    Med Microbiol Immunol, 196(3): 151-5. [Abstract] [Full-text]
12. The influence of measles vaccination on the incidence of otosclerosis in Germany.
    Eur Arch Otorhinolaryngol, 264(7): 741-748. [Abstract] [Full-text]
13. Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple.
    Pediatr Res, 62(1): 111-5. [Abstract] [Full-text]
14. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.
    Eur J Pediatr, 166(8): 857-64. [Abstract] [Full-text]
15. Involvement of morbilliviruses in the pathogenesis of demyelinating disease.
    Rev Med Virol, 17(4): 223-44. [Abstract] [Full-text]
16. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system.
    BMC Neurol, 7: 12. [Abstract] [Full-text]
17. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
    J Infect Dis, 196(3): 347-55. [Abstract] [Full-text]
18. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in europe: a role for the combined vaccine.
    Pediatr Infect Dis J, 26(7): 632-8. [Abstract] [Full-text]
19. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies.
    Trop Med Int Health, 12(7): 815-22. [Abstract] [Full-text]

© 2004-2010 Measles Research Today. All Rights Reserved.